Skyward Specialty Announces Secondary Offering of Its Common Stock
06 Maggio 2024 - 1:12PM
Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) (“Skyward
Specialty” or the “Company”) a leader in the specialty property and
casualty (“P&C”) market, announced that The Westaim Corporation
(“Westaim”), through its wholly-owned subsidiary, Westaim HIIG GP
Inc. (the “Selling Stockholder”) is offering 4,400,000 shares of
the Company’s common stock in an underwritten secondary public
offering. In connection with the offering, the Selling Stockholder
has also granted the underwriters a 30-day option to purchase up to
an additional 660,000 shares of Skyward Specialty's common stock.
The Selling Stockholder will be a 4.80% and 6.45% shareholder in
Skyward Specialty, assuming full and no exercise of the
underwriters’ option to purchase the additional shares,
respectively.
Skyward Specialty will not receive any of the
proceeds from the sale of the shares of its common stock offered by
the Selling Stockholder, and the Selling Stockholder will bear the
underwriting discounts and commissions associated with the sale of
such shares.
Barclays, Keefe, Bruyette & Woods, Inc., A
Stifel Company, and Jefferies are acting as joint lead book-running
managers for the proposed offering.
The offering is being made pursuant to an
automatically effective shelf registration statement on Form S-3
filed with the Securities and Exchange Commission (the “SEC”) on
May 6, 2024 and only by means of a preliminary prospectus
supplement. A copy of the preliminary prospectus supplement and
accompanying prospectus relating to the offering may be obtained,
when available, by visiting the SEC website at www.sec.gov or from
Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155
Long Island Avenue, Edgewood, NY 11717 (telephone: (888) 603-5847
or email: Barclaysprospectus@broadridge.com), Keefe, Bruyette &
Woods, Inc., 787 Seventh Ave., 4th Floor, New York, New York 10019,
Attention: Equity Capital Markets (telephone: (800) 966-1559 or
email: kbwsyndicatedesk@kbw.com) or Jefferies LLC, 520 Madison
Avenue, New York, NY 10022, Attention: Equity Syndicate Prospectus
Department (telephone: (877) 821-7388, or email:
prospectus_department@jefferies.com).
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy, nor shall there be
any sale of these securities in any state or jurisdiction in which
such offer, solicitation, or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction.
About Skyward SpecialtySkyward Specialty
(NASDAQ: SKWD) is a rapidly growing and innovative specialty
insurance company, delivering commercial property and casualty
products and solutions on a non-admitted and admitted basis. The
Company operates through eight underwriting divisions -- Accident
& Health, Captives, Global Property & Agriculture, Industry
Solutions, Professional Lines, Programs, Surety and Transactional
E&S.
Skyward Specialty's subsidiary insurance companies consist of
Houston Specialty Insurance Company, Imperium Insurance Company,
Great Midwest Insurance Company, and Oklahoma Specialty Insurance
Company. These insurance companies are rated A- (Excellent) by A.M.
Best Company with positive outlook. For more information about
Skyward Specialty, its people, and its products, please
visit skywardinsurance.com.
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING
STATEMENTS
Certain statements contained in this press release constitute
forward-looking statements, including with respect to statements
relating to the offering, including the timing and size of the
offering and the grant of the option to purchase additional shares.
Management has based these forward-looking statements on its
current expectations, assumptions, estimates and projections. While
they believe these expectations, assumptions, estimates and
projections are reasonable, such forward-looking statements are
only predictions and involve known and unknown risks and
uncertainties, many of which are beyond management's control. These
statements involve risks and uncertainties that may cause Skyward
Specialty's actual results, performance or achievements to differ
materially from any future results, performance or achievements
expressed or implied by these forward-looking statements,
including, without limitation: the risks and uncertainties with
market conditions and the satisfaction of customary closing
conditions related to the proposed offering and the other risks and
uncertainties described in Skyward Specialty’s filings with the
SEC, included under the heading “Risk Factors” in Skyward
Specialty’s Annual Report on Form 10-K and any subsequent filings
with the SEC. Forward-looking statements speak only as of the date
they are made. Readers are cautioned not to put undue reliance on
forward-looking statements, and, except as required by law, Skyward
Specialty assumes no obligation and does not intend to update or
revise these forward-looking statements, whether as a result of new
information, future events, or otherwise. All forward-looking
statements are qualified in their entirety by this cautionary
statement, which is made under the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995.
Media ContactHaley DoughtySkyward Specialty
Insurance Group713-935-4944hdoughty@skywardinsurance.com
Investor RelationsNatalie
Schoolcraft614-494-4988nschoolcraft@skywardinsurance.com
Grafico Azioni Skyward Specialty Insura... (NASDAQ:SKWD)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Skyward Specialty Insura... (NASDAQ:SKWD)
Storico
Da Gen 2024 a Gen 2025